Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Total 13F shares
-
19,141,323
-
Share change
-
+479,760
-
Total reported value
-
$568,487,585
-
Put/Call ratio
-
66%
-
Price per share
-
$29.70
-
Number of holders
-
85
-
Value change
-
+$17,146,600
-
Number of buys
-
47
-
Number of sells
-
36
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2016
As of 30 Sep 2016,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,141,323 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, DRIEHAUS CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, Opaleye Management Inc., VANGUARD GROUP INC, Boxer Capital, LLC, and FIL Ltd.
This page lists
85
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.